WebMD Health (WBMD) Reports In-Line Q1 EPS, Affirms FY Guidance, Q2 Revenue Misses

WebMD Health (NASDAQ: WBMD) reported Q1 EPS of $0.22, in-line with the analyst estimate of $0.22. Revenue for the quarter came in at $143.3 million versus the consensus estimate of $142.1 million.

WebMD Health sees Q2 2015 revenue of $145-148 million, versus the consensus of $151.85 million.

• Adjusted EBITDA is expected to be approximately $38 million to $39.5 million, an increase of approximately 0% to 4% from the prior year period.
• Net income to be approximately $8.5 million to $9.5 million.

Today, WebMD reaffirmed its guidance for 2015 that was previously provided on February 24, 2015.

For the full year ending December 31, 2015, WebMD continues to expect:

Revenue to be approximately $615 million to $635 million, an increase of approximately 6% to 9% from the prior year.

Approximately $486 million to $502 million of revenue is expected to be from advertising and sponsorship, an increase of 7% to 11% from the prior year. Growth in advertising and sponsorship will be driven by growth in revenue from biopharma and medical device customers of approximately 12% to 15% in 2015.
Approximately $105 million to $108 million of revenue is expected to be from private portals services, an increase of 2% to 5% from the prior year.
Approximately $24 million to $25 million of revenue is expected to be from information services, an increase of 3% to 7% from the prior year.

Adjusted EBITDA to be approximately $180 million to $190 million, an increase of approximately 13% to 20% from the prior year.
Net income to be approximately $50.5 million to $59.5 million.

For earnings history and earnings-related data on WebMD Health (WBMD) click here.

You May Also Be Interested In

• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• QNB Corp. (QNBC) Reports Q1 EPS of $0.71
• Simmons First National Corp (SFNC) Misses Q1 EPS by 1c